162 related articles for article (PubMed ID: 38000108)
1. Fatty Liver Index as a proxy for non-alcoholic fatty liver disease and the risk of stroke and coronary heart disease: The Suita Study.
Arafa A; Kashima R; Matsumoto C; Kokubo Y
J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107495. PubMed ID: 38000108
[TBL] [Abstract][Full Text] [Related]
2. Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study.
Kim JH; Moon JS; Byun SJ; Lee JH; Kang DR; Sung KC; Kim JY; Huh JH
Cardiovasc Diabetol; 2020 May; 19(1):51. PubMed ID: 32359355
[TBL] [Abstract][Full Text] [Related]
3. Association of fatty liver index with the risk of incident cardiovascular disease and acute myocardial infarction.
Olubamwo OO; Virtanen JK; Voutilainen A; Kauhanen J; Pihlajamäki J; Tuomainen TP
Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1047-1054. PubMed ID: 29912803
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes.
Li M; Zhao Z; Qin G; Chen L; Lu J; Huo Y; Chen L; Zeng T; Xu M; Chen Y; Wang T; Wang S; Xu Y; Shi L; Tang X; Su Q; Yu X; Yan L; Wan Q; Chen G; Gao Z; Wang G; Shen F; Luo Z; Zhang Y; Liu C; Wang Y; Hu R; Ye Z; Wu S; Deng H; Yang T; Li Q; Qin Y; Mu Y; Zhao J; Ning G; Bi Y; Xu Y; Wang W
Metabolism; 2021 Nov; 124():154874. PubMed ID: 34517014
[TBL] [Abstract][Full Text] [Related]
5. Fatty Liver Index and the Risk of Atrial Fibrillation in a General Japanese Population - The Suita Study.
Arafa A; Kokubo Y; Kashima R; Matsumoto C; Teramoto M; Kusano K
Circ J; 2023 Nov; 87(12):1836-1841. PubMed ID: 37743519
[TBL] [Abstract][Full Text] [Related]
6. Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study.
Fresneda S; Abbate M; Busquets-Cortés C; López-González A; Fuster-Parra P; Bennasar-Veny M; Yáñez AM
Biol Sex Differ; 2022 Nov; 13(1):64. PubMed ID: 36333736
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes.
Mantovani A; Mingolla L; Rigolon R; Pichiri I; Cavalieri V; Zoppini G; Lippi G; Bonora E; Targher G
Int J Cardiol; 2016 Dec; 225():387-391. PubMed ID: 27768965
[TBL] [Abstract][Full Text] [Related]
8. The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study.
Lee CH; Han KD; Kim DH; Kwak MS
Front Endocrinol (Lausanne); 2021; 12():638615. PubMed ID: 33776934
[TBL] [Abstract][Full Text] [Related]
9. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
[TBL] [Abstract][Full Text] [Related]
10. The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study.
Park J; Kim G; Kim BS; Han KD; Kwon SY; Park SH; Lee YB; Jin SM; Kim JH
Cardiovasc Diabetol; 2022 Apr; 21(1):53. PubMed ID: 35429980
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk factors in non-alcoholic fatty liver disease.
Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Askling J; Hultcrantz R; Kechagias S
Liver Int; 2019 Jan; 39(1):197-204. PubMed ID: 30253056
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults.
Alexander M; Loomis AK; van der Lei J; Duarte-Salles T; Prieto-Alhambra D; Ansell D; Pasqua A; Lapi F; Rijnbeek P; Mosseveld M; Avillach P; Egger P; Dhalwani NN; Kendrick S; Celis-Morales C; Waterworth DM; Alazawi W; Sattar N
BMJ; 2019 Oct; 367():l5367. PubMed ID: 31594780
[TBL] [Abstract][Full Text] [Related]
13. Non-High-Density Lipoprotein Cholesterol and Risk of Stroke Subtypes and Coronary Heart Disease: The Japan Public Health Center-Based Prospective (JPHC) Study.
Saito I; Yamagishi K; Kokubo Y; Yatsuya H; Iso H; Sawada N; Inoue M; Tsugane S
J Atheroscler Thromb; 2020 Apr; 27(4):363-374. PubMed ID: 31534078
[TBL] [Abstract][Full Text] [Related]
14. Urinary Stones and Risk of Coronary Heart Disease and Stroke: the Japan Public Health Center-Based Prospective Study.
Arafa A; Eshak ES; Iso H; Shirai K; Muraki I; Sawada N; Tsugane S;
J Atheroscler Thromb; 2020 Nov; 27(11):1208-1215. PubMed ID: 32507830
[TBL] [Abstract][Full Text] [Related]
15. The Association between Nonalcoholic Fatty Liver Disease and Stroke: Results from the Korean Genome and Epidemiology Study (KoGES).
Yang YJ; Jung MH; Jeong SH; Hong YP; Kim YI; An SJ
Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33371282
[TBL] [Abstract][Full Text] [Related]
16. Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study.
Garofolo M; Lucchesi D; Giambalvo M; Aragona M; Bertolotto A; Campi F; Bianchi C; Francesconi P; Marchetti P; Del Prato S; Penno G
Cardiovasc Diabetol; 2024 Feb; 23(1):85. PubMed ID: 38419065
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of non-alcoholic fatty liver disease in patients with a first episode of acute ischemic stroke. Impact on disability and death.
Canillas L; Soriano-Varela A; Rodríguez-Campello A; Giralt-Steinhauer E; Cuadrado-Godia E; Broquetas T
Front Endocrinol (Lausanne); 2022; 13():1003878. PubMed ID: 36589812
[TBL] [Abstract][Full Text] [Related]
18. Association between nonalcoholic fatty liver disease and cardiovascular disease revealed after comprehensive control of metabolic risk factors: a nationwide population-based study in Korea.
Seo BS; Roh JH; Lee JH; Lee H; Min Kim Y; Yoon YH; Kim M; Kim YG; Park GM; Park JH; Seong IW
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e375-e382. PubMed ID: 33731579
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.
Motamed N; Rabiee B; Poustchi H; Dehestani B; Hemasi GR; Khonsari MR; Maadi M; Saeedian FS; Zamani F
Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):31-38. PubMed ID: 27597641
[TBL] [Abstract][Full Text] [Related]
20. Development of new scores for atherosclerotic cardiovascular disease using specific medical examination items: the Suita Study.
Arafa A; Kashima R; Yasui Y; Kawachi H; Matsumoto C; Nosaka S; Teramoto M; Matsuo M; Kokubo Y
Environ Health Prev Med; 2023; 28():61. PubMed ID: 37899208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
